Not Yet Recruiting
Potency of HDM Sublingual AIT Tablets in Assuring the Persistency of Asthma Control in HDM Allergic Patients With Severe Asthma, Treated With Tezepelumab
NCT07013123
- Conditions
- Allergy to House Dust Mites, Asthma, Bronchial Diseases, +14 more
- Locations
-
Not specified